Supplemental Table S6 from Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype

Key Points

• Cytotoxic NK cells significantly impede response to checkpoint immunotherapy in melanoma.
• Study identifies specific marker genes associated with immune-excluded phenotypes in melanoma.
• Subclustering of DCs and monocytes reveals distinct gene expressions linked to treatment outcomes.
• Findings highlight the need for tailored approaches in immunotherapy for melanoma patients.